Independent Labs, Institutes, and Centers (Dean of Research)
Showing 1-50 of 131 Results
-
Shamit Kachru
Professor of Physics and Director, Stanford Institute for Theoretical Physics, Emeritus
Current Research and Scholarly InterestsMy current research is focused in three directions:
— Mathematical aspects of string theory (with a focus on BPS state counts, black holes, and moonshine)
— Quantum field theory approaches to condensed matter physics (with a focus on physics of non-Fermi liquids)
— Theoretical biology, with a focus on evolution and ecology -
Deborah Kado
Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Epidemiology and Population Health
BioDr. Kado is a board-certified, fellowship-trained doctor specializing in geriatrics. She serves as co-director of the Stanford Longevity Center. She is a professor of medicine and chief of research for the Geriatrics Section in the Department of Medicine, Division of Primary Care and Population Health. She is also the Director of the Geriatric Research, Education, and Clinical Center (GRECC) at VA Palo Alto Health Care System.
For each patient, Dr. Kado prepares a personalized care plan. Her objective is to help all individuals maintain the best possible health and quality of life as they age.
A special interest of Dr. Kado is bone health. She has conducted extensive research focused on osteoporosis and the related disorder hyperkyphosis.
Since joining the UCLA faculty in 2000, she has received continuous funding for her research from the National Institutes of Health (NIH).
She has over 100 peer-reviewed publications of her research findings in the Journal of Bone and Mineral Research, Osteoporosis International, Journal of Gerontology and Medical Sciences, Journal of Geriatric Oncology, Nature Communications, and other peer-reviewed journals.
In 2007, she defined hyperkyphosis as a new geriatric syndrome. Her discoveries in this field were first featured in the American College or Physician’s premier internal medicine journal Annals of Internal Medicine. Later, they also appeared in a dedicated chapter in UpToDate, the electronic resource providing evidence-based clinical decision support for doctors worldwide.
Prior to coming to Stanford, Dr. Kado practiced at UC San Diego where she started a dedicated osteoporosis clinic for patient care and research. She later broadened her research interests beyond musculoskeletal aging to study other aging-related topics such as the gut microbiome in older men and the effects of cancer treatments on aging in newly diagnosed breast cancer patients.
Dr. Kado is a California native. She trained at UCSF and UCLA. She also earned a Master of Science degree in epidemiology at the UCLA School of Public Health, sponsored by the John Hartford Foundation.
She is a member of the American Geriatrics Society, American Society of Bone and Mineral Research, Gerontological Society of America, The Endocrine Society, and other professional organizations. She co-chairs the NIH National Institute on Aging Workshop for the American Society of Bone and Mineral Research. She also participates in the Bone Health Working Group of the Society for Women’s Health Research. -
Colin Kahl
Senior Fellow at the Freeman Spogli Institute for International Studies and Professor, by courtesy, of Political Science
BioColin H. Kahl is co-director of the Center for International Security and Cooperation, the inaugural Steven C. Házy Senior Fellow at the Freeman Spogli Institute for International Studies, and a Professor, by courtesy, in the Department of Political Science at Stanford University. He is also a Strategic Consultant to the Penn Biden Center for Diplomacy and Global Engagement.
From October 2014 to January 2017, he was Deputy Assistant to the President and National Security Advisor to the Vice President. In that position, he served as a senior advisor to President Obama and Vice President Biden on all matters related to U.S. foreign policy and national security affairs, and represented the Office of the Vice President as a standing member of the National Security Council Deputies’ Committee. From February 2009 to December 2011, Dr. Kahl was the Deputy Assistant Secretary of Defense for the Middle East at the Pentagon. In this capacity, he served as the senior policy advisor to the Secretary of Defense for Egypt, Iran, Iraq, Israel and the Palestinian territories, Saudi Arabia, Syria, Yemen, and six other countries in the Levant and Persian Gulf region. In June 2011, he was awarded the Secretary of Defense Medal for Outstanding Public Service by Secretary Robert Gates.
From 2007 to 2017 (when not serving in the U.S. government), Dr. Kahl was an assistant and associate professor in the Security Studies Program at Georgetown University's Edmund A. Walsh School of Foreign Service. From 2007 to 2009 and 2012 to 2014, he was also a Senior Fellow at the Center for a New American Security (CNAS), a nonpartisan Washington, DC-based think tank. From 2000 to 2007, he was an assistant professor of political science at the University of Minnesota. In 2005-2006, Dr. Kahl took leave from the University of Minnesota to serve as a Council on Foreign Relations International Affairs Fellow in the Office of the Secretary of Defense, where he worked on issues related to counterinsurgency, counterterrorism, and responses to failed states. In 1997-1998, he was a National Security Fellow at the John M. Olin Institute for Strategic Studies at Harvard University.
Current research includes an assessment of American grand strategy in the Middle East in the post-9/11 era. A second research project focuses on the implications of emerging technologies on nuclear strategic stability.
He has published numerous articles on international security and U.S. foreign and defense policy in Foreign Affairs, Foreign Policy, International Security, the Los Angeles Times, Middle East Policy, the National Interest, the New Republic, the New York Times, Politico, the Washington Post, and the Washington Quarterly, as well as several reports for CNAS.
His previous research analyzed the causes and consequences of violent civil and ethnic conflict in developing countries, focusing particular attention on the demographic and natural resource dimensions of these conflicts. His book on the subject, States, Scarcity, and Civil Strife in the Developing World, was published by Princeton University Press in 2006, and related articles and chapters have appeared in International Security, the Journal of International Affairs, and various edited volumes.
Dr. Kahl received his B.A. in political science from the University of Michigan (1993) and his Ph.D. in political science from Columbia University (2000). -
Joseph Kahn
Professor of Electrical Engineering
BioJoseph M. Kahn is a Professor of Electrical Engineering at Stanford University. His research addresses communication and imaging through optical fibers, including modulation, detection, signal processing and spatial multiplexing. He received A.B. and Ph.D. degrees in Physics from U.C. Berkeley in 1981 and 1986. From 1987-1990, he was at AT&T Bell Laboratories, Crawford Hill Laboratory, in Holmdel, NJ. He was on the Electrical Engineering faculty at U.C. Berkeley from 1990-2003. In 2000, he co-founded StrataLight Communications, which was acquired by Opnext, Inc. in 2009. He received the National Science Foundation Presidential Young Investigator Award in 1991 and is a Fellow of the IEEE.
-
A Dale Kaiser
Member, Bio-X
Current Research and Scholarly InterestsHow are genes regulated to construct a developmental program? How do signals received from other cells change the program and coordinate it for multicellular development? The approach taken by our laboratory group to answer these questions utilizes biochemistry and genetics; genetics to isolate mutants that have particular defects in development and biochemistry to determine the molecular basis of the defects. We study swarming in Myxococcus xanthus that builds fruiting bodies.
-
Anusha Kalbasi, MD
Associate Professor of Radiation Oncology (Radiation Therapy)
BioDr. Kalbasi is radiation oncologist and physician-scientist at the Stanford Cancer Institute, specializing in the treatment of patients with solid malignancies, especially sarcoma and melanoma. He actively leads early phase clinical trials related to immunotherapy and/or radiation therapy.
Dr. Kalbasi's laboratory studies cancer immunology, with a focus on manipulating the cell-intrinsic signals of immune cells and cancer cells to influence the outcomes of immunotherapy and/or radiation. The lab integrates a variety of approaches including cell and protein engineering, synthetic biology, cell signaling, genomics, and analysis of samples from patients on clinical trials. The lab is actively engaged in projects involving engineering T cell therapies (TCR, CAR, TIL), T cell engagers, cytokine therapies, innate immune agonists and radiation therapy.
Dr. Kalbasi was previously assistant professor of radiation oncology at the David Geffen School of Medicine at UCLA and chief of sarcoma radiotherapy at the UCLA Jonsson Comprehensive Cancer Center, where he was named a NextGen Star by the American Association of Cancer Research. Dr. Kalbasi’s work has been published in leading journals including Nature, Science Translational Medicine, JAMA Oncology, Lancet Oncology, Nature Cancer and Cancer Discovery. -
Julia Kaltschmidt
Associate Professor of Neurosurgery
Current Research and Scholarly InterestsThe lab’s primary research interest is to understand how specific neuronal circuits are established. We use mouse genetics, combinatorial immunochemical labeling and high-resolution laser scanning microscopy to identify, manipulate, and quantitatively analyze synaptic contacts within the complex neuronal milieu of the spinal cord and the enteric nervous system.
-
Robin Kamal MD MBA
Associate Professor of Orthopaedic Surgery and, by courtesy, of Surgery (Plastic and Reconstructive Surgery)
On Partial Leave from 03/03/2025 To 04/02/2025Current Research and Scholarly InterestsWrist and Elbow Injuries and Quality Measures in Orthopaedic Surgery
-
Tahereh Kamali
Instructor, Adult Neurology
Current Research and Scholarly InterestsAI for Healthcare, Neuroimaging, Biomarkers Development
-
Aya Kamaya, MD
Professor of Radiology (Body Imaging)
On Leave from 02/18/2025 To 04/25/2025Current Research and Scholarly InterestsHepatobiliary imaging
Hepatocellular carcinoma
Urologic imaging
Gynecologic imaging
Thyroid imaging
Novel ultrasound technologies
Perfusion CT imaging of abdominal tumors -
Theodore Kamins
Adjunct Professor, Electrical Engineering
Researcher, Hansen Experimental Physics Laboratory (HEPL)BioTed received his degrees from the University of California, Berkeley. He then joined the Research and Development Laboratory of Fairchild Semiconductor, where he worked with epitaxial and polycrystalline silicon before moving to Hewlett-Packard Laboratories, where he worked on numerous semiconductor material and device topics. Before moving to Stanford, he was a Principal Scientist at Hewlett-Packard in the Information and Quantum Systems Laboratory, where he conducted research on advanced nanostructured electronic and sensing materials and devices.
Ted is co-author with R. S. Muller of the textbook "Device Electronics for Integrated Circuits" and is author of the book "Polycrystalline Silicon for Integrated Circuits and Displays." He is a Fellow of the IEEE and a Fellow of the Electrochemical Society. He has taught at the University of California, Berkeley, and at Stanford University and has been an Associate Editor of the IEEE Transactions on Electron Devices. -
Matthew Kanan
Professor of Chemistry and Senior Fellow at the Precourt Institute for Energy
BioMatt Kanan is a Professor of Chemistry and Director of the TomKat Center for Sustainable Energy at Stanford. Matt’s research group addresses challenges in energy conversion, sustainable resource utilization, and carbon dioxide removal. Their work has led to several inventions in these areas, including process technology that utilizes CO2 to streamline chemical production, metal-free CO2 hydrogenation catalysts that improve the efficiency of sustainable fuel synthesis, membrane-free electrochemical systems to generate acid and base from water, and thermochemical methods to activate silicate rocks for CO2 removal. Matt is the co-founder and Chief Scientific Advisor for ReSource Chemical Corp., an Oakland-based start-up commercializing a process created in his group to produce performance-advantaged plastics from CO2 and inedible biomass. At the TomKat Center, Matt directs programs that help Stanford students and researchers develop and commercialize innovations that impact energy and sustainability. Prior to joining the Stanford faculty in 2009, Matt did his Ph.D. studies in organic chemistry at Harvard and postdoctoral research at MIT in inorganic chemistry. He earned his B.A. in chemistry from Rice University in 2000.
-
Peter Kao
Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsOur research program has several active projects:
1.) Pulmonary Vascular Disease Simvastatin reversed experimental pulmonary hypertension, and is safe for treatment of patients. Blinded clinical trials of efficacy are in progress.
2.) Lung inflammation and regeneration (stem cells)
3.) Lung surfactant rheology and oxidative stress
4.) Gene regulation by RNA binding proteins, NF45 and NF90 through transcriptional and posttranscriptional mechanisms -
Zerina Kapetanovic
Assistant Professor of Electrical Engineering and, by courtesy, of Computer Science and of Geophysics
BioZerina Kapetanovic is an Assistant Professor in the Department of Electrical Engineering at Stanford University working in the area of low-power wireless communication, sensing, and Internet of Things (IoT) systems. Prior to starting at Stanford, Kapetanovic was a postdoctoral researcher at Microsoft Research in the Networking Research Group and Research for Industry Group.
Kapetanovic's research has been recognized by the Yang Research Award, the Distinguished Dissertation Award from the University of Washington. She also received the Microsoft Research Distinguished Dissertation Grant and was selected to attend the 2020 UC Berkeley Rising Stars in EECS Workshop. Kapetanovic completed her PhD in Electrical Engineering from the University of Washington in 2022. -
Aharon Kapitulnik
Theodore and Sydney Rosenberg Professor of Applied Physics and Professor of Physics
On Leave from 01/01/2025 To 06/30/2025BioAharon Kapitulnik is the Theodore and Sydney Rosenberg Professor in Applied Physics at the Departments of Applied Physics and Physics at Stanford University. His research focuses on experimental condensed matter physics, while opportunistically, also apply his methods to tabletop experimental studies of fundamental phenomena in physics. His recent studies cover a broad spectrum of phenomena associated with the behavior of correlated and disordered electron systems, particularly in reduced dimensions, and the development of effective instrumentation to detect subtle signatures of physical phenomena.
Among other recognitions, his activities earned him the Alfred P. Sloan Fellowship (1986-90), a Presidential Young Investigator Award (1987-92), a Sackler Scholar at Tel-Aviv University (2006), the Heike Kamerlingh Onnes Prize for Superconductivity Experiment (2009), a RTRA (Le Triangle de la Physique) Senior Chair (2010), and the Oliver Buckley Condensed Matter Prize of the American Physical Society (2015). Aharon Kapitulnik is a Fellow of the American Physical Society, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Association for the Advancement of Science and a member of the National Academy of Sciences. Kapitulnik holds a Ph.D. in Physics from Tel-Aviv University (1984). -
Omer Karaduman
Assistant Professor of Operations, Information and Technology at the Graduate School of Business and Center Fellow at the Stanford Institute for Economic Policy Research and at the Precourt Institute for Energy
BioPrior to coming to Stanford, Omer completed his Ph.D. in Economics at MIT in 2020, and got his bachelor's degree in Economics from Bilkent University in 2014.
His research focuses on the transition of the energy sector towards a decarbonized and sustainable future. In his research, he utilizes large datasets by using game-theoretical modeling to have practical policy suggestions. -
Ioannis Karakikes
Associate Professor (Research) of Cardiothoracic Surgery
Current Research and Scholarly InterestsThe Karakikes Lab aims to uncover fundamental new insights into the molecular mechanisms and functional consequences of pathogenic mutations associated with familial cardiovascular diseases.
-
Hemamala Karunadasa
J.G. Jackson and C.J. Wood Professor of Chemistry and Senior Fellow at the Precourt Institute for Energy
BioProfessor Hema Karunadasa works with colleagues in materials science, earth science, and applied physics to drive the discovery of new materials with applications in clean energy. Using the tools of synthetic chemistry, her group designs materials that couple the structural tunability of organic molecules with the diverse electronic and optical properties of extended inorganic solids. This research targets materials such as sorbents for capturing environmental pollutants, phosphors for solid-state lighting, and absorbers for solar cells.
Hemamala Karunadasa studied chemistry and materials science at Princeton University (A.B. with high honors 2003; Certificate in Materials Science and Engineering 2003), where her undergraduate thesis project with Professor Robert J. Cava examined geometric magnetic frustration in metal oxides. She moved from solid-state chemistry to solution-state chemistry for her doctoral studies in inorganic chemistry at the University of California, Berkeley (Ph.D. 2009) with Professor Jeffrey R. Long. Her thesis focused on heavy atom building units for magnetic molecules and molecular catalysts for generating hydrogen from water. She continued to study molecular electrocatalysts for water splitting during postdoctoral research with Berkeley Professors Christopher J. Chang and Jeffrey R. Long at the Lawrence Berkeley National Lab. She further explored molecular catalysts for hydrocarbon oxidation as a postdoc at the California Institute of Technology with Professor Harry B. Gray. She joined the Stanford Chemistry Department faculty in September 2012. Her research explores solution-state routes to new solid-state materials.
Professor Karunadasa’s lab at Stanford takes a molecular approach to extended solids. Lab members gain expertise in solution- and solid-state synthetic techniques and structure determination through powder- and single-crystal x-ray diffraction. Lab tools also include a host of spectroscopic and electrochemical probes, imaging methods, and film deposition techniques. Group members further characterize their materials under extreme environments and in operating devices to tune new materials for diverse applications in renewable energy.
Please visit the lab website for more details and recent news. -
Maya M. Kasowski
Assistant Professor of Pathology, of Medicine (Pulmonary, Allergy and Critical Care Medicine) and, by courtesy, of Genetics
BioI am a clinical pathologist and assistant professor in the Departments of Medicine, Pathology, and Genetics (by courtesy) at Stanford. I completed my MD-PhD training at Yale University and my residency training and a post-doctoral fellowship in the Department of Genetics at Stanford University. My experiences as a clinical pathologist and genome scientist have made me passionate about applying cutting-edge technologies to primary patient specimens in order to characterize disease pathologies at the molecular level. The core focus of my lab is to study the mechanisms by which genetic variants influence the risk of disease through effects on intermediate molecular phenotypes.
-
Riitta Katila
W.M. Keck Professor and Professor of Management Science and Engineering
Current Research and Scholarly InterestsThe question that drives Prof. Katila's research is how technology-based firms with significant resources can stay innovative. Her work lies at the intersection of the fields of technology, innovation, and strategy and focuses on strategies that enable organizations to discover, develop and commercialize technologies. She combines theory with longitudinal large-sample data (e.g., robotics, biomedical, platform and multi-industry datasets), background fieldwork, and state-of-the-art quantitative methods. The ultimate objective is to understand what makes technology-based firms successful.
To answer this question, Prof. Katila conducts two interrelated streams of research. She studies (1) strategies that help firms leverage their existing resources (leverage stream), and (2) strategies through which firms can acquire new resources (acquisition stream) to create innovation. Her early contributions were firm centric while recent contributions focus on innovation in the context of competitive interaction and ecosystems.
Professor Katila's work has appeared in the Academy of Management Journal, Administrative Science Quarterly, Organization Science, Strategic Entrepreneurship Journal, Strategy Science, Strategic Management Journal, Research Policy and other outlets. In her work, supported by the National Science Foundation, Katila examines how firms create new products successfully. Focusing on the robotics and medical device industries, she investigates how different search approaches, such as the exploitation of existing knowledge and the exploration for new knowledge, influence the kinds of new products that technology-intensive firms introduce. -
Daniel Katz
Assistant Professor of Medicine (BMIR)
BioDaniel Katz is an Assistant Professor of Medicine in the Stanford Center for Biomedical Informatics Research (BMIR) and the Cardiovascular Medicine Divisions. He practices as an Advanced Heart Failure and Transplant Cardiologist. He completed internal medicine residency at Massachusetts General Hospital, general cardiology training at Beth Israel Deaconess Medical Center, and then joined Stanford in 2021 for his advanced heart failure training. Since medical school, his research has focused on identifying the various pathophysiologic patterns and mechanisms that lead to the heterogeneous syndrome of heart failure. His efforts leverage high dimensional data in many forms including clinical phenotypes, plasma proteomics, metabolomics, and genetics. He is presently engaged in analysis of multi-omic data from the Molecular Transducers of Physical Activity Consortium (MoTrPAC) and the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program. His clinical interests include advanced heart failure, transplant cardiology, and mechanical circulatory support.
-
Noa Katz
Postdoctoral Scholar, Chemical Engineering
BioNoa Katz is a Stanford Science Fellow and an EMBO and Fulbright postdoctoral scholar at Stanford University. She implements biomolecular gene circuits to study and manipulate the central nervous system to promote therapeutic applications for neural repair and autism.
-
Laurence Katznelson, MD
Professor of Neurosurgery, Emeritus
Current Research and Scholarly InterestsDr. Katznelson is an internationally known neuroendocrinologist and clinical researcher, with research expertise in the diagnosis and management of hypopituitarism, the effects of hormones on neurocognitive function, and the development of therapeutics for acromegaly and Cushings syndrome, and neuroendocrine tumors. Dr. Katznelson is the medical director of the multidisciplinary Stanford Pituitary Center, a program geared for patient management, clinical research and patient education
-
Amit Kaushal
Adjunct Professor, Bioengineering
BioAmit Kaushal, MD, PhD is Clinical Associate Professor of Medicine (Stanford-VA) and Adjunct Professor of Bioengineering at Stanford University. Dr. Kaushal's work spans clinical medicine, teaching, research, and industry.
He helped launch Stanford School of Engineering's undergraduate major in Biomedical Computation (bmc.stanford.edu) and has served as long-time director of the major. The major has graduated over 70 students since inception and was recently featured in Nature (https://go.nature.com/2P2UnRu).
His research interests are in utilizing health data in novel and ethical ways to improve the practice of medicine. He is a faculty executive member of Stanford's Partnership for AI-Assisted Care (aicare.stanford.edu). Recently, he has also been working with public health agencies to improve scale and speed of contact tracing for COVID-19.
He has previously held executive and advisory roles at startups working at the interface of technology and healthcare.
He continues to practice as an academic hospitalist.
Dr. Kaushal completed his BS (Biomedical Computation), MD, PhD (Biomedical Informatics), and residency training at Stanford. He is board-certified in Internal Medicine and Clinical Informatics. -
Makoto Kawai
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioI am a physician scientist in the field of sleep medicine in aging and brain function. Using combined polysomnogram and novel neuroimaging technology, I aim to identify potential sleep biomarkers to investigate the mechanism of progression from normal aging to Mild Cognitive Impairment (MCI) or dementia. I also investigate the impact of sleep on cognitive/affective function or behavior abnormality in various neurodevelopmental and neurodegenerative disorders.
-
Mark A. Kay, M.D., Ph.D.
Dennis Farrey Family Professor of Pediatrics, and Professor of Genetics
Current Research and Scholarly InterestsMark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.
-
Electron Kebebew, MD, FACS
Harry A. Oberhelman, Jr. and Mark L. Welton Professor
Current Research and Scholarly InterestsDr. Kebebew’s translational and clinical investigations have three main scientific goals: 1) to develop effective therapies for fatal, rare and neglected endocrine cancers, 2) to identify new methods, strategies and technologies for improving the diagnosis and treatment of endocrine neoplasms and the prognostication of endocrine cancers, and 3) to develop methods for precision treatment of endocrine tumors.
-
Corey Keller, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsThe goal of my lab is to understand the fundamental principles of human brain plasticity and build trans-diagnostic real-time monitoring platforms for personalized neurotherapeutics.
We use an array of neuroscience methods to better understand the basic principles of how to create change in brain circuits. We use this knowledge to develop more effective treatment strategies for depression and other psychiatric disorders. -
Kevin Kelley
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioAs a neuroscientist and psychiatrist, I am motivated by how little we understand about the pathophysiology of psychiatric disorders and hope that further knowledge will help to alleviate the ongoing distress of many of our patients. My research program leverages computational genomics, human brain cellular models, and molecular neuroscience techniques to understand the cellular and molecular mechanisms of human brain development and how dysfunction in these processes lead to psychiatric disorders.
-
Monroe Kennedy III
Assistant Professor of Mechanical Engineering
Current Research and Scholarly InterestsMy research focus is to develop technology that improves everyday life by anticipating and acting on the needs of human counterparts. My research can be divided into the following sub-categories: robotic assistants, connected devices and intelligent wearables. My Assistive Robotics and Manipulation lab focuses heavily on both the analytical and experimental components of assistive technology design.
-
Thomas Kenny
Senior Associate Dean for Education and Student Affairs and Richard W. Weiland Professor in the School of Engineering
BioKenny's group is researching fundamental issues and applications of micromechanical structures. These devices are usually fabricated from silicon wafers using integrated circuit fabrication tools. Using these techniques, the group builds sensitive accelerometers, infrared detectors, and force-sensing cantilevers. This research has many applications, including integrated packaging, inertial navigation, fundamental force measurements, experiments on bio-molecules, device cooling, bio-analytical instruments, and small robots. Because this research field is multidisciplinary in nature, work in this group is characterized by strong collaborations with other departments, as well as with local industry.
-
Khizer Khaderi MD, MPH
Clinical Associate Professor, Ophthalmology
BioDr. Khizer Khaderi is a Clinical Associate Professor at the Byers Eye Institute at Stanford University. Khaderi is the Founding Director of the Stanford Human Perception Laboratory (HPL) and the Stanford Vision Performance Center (VPC). He also serves as faculty at the Stanford Institute for Human-Centered AI and the Wu Tsai Human Performance Alliance (HPA)
Khaderi is a renowned Neuro-Ophthalmic surgeon, technologist and futurist. Dr. Khaderi is pioneering the field of Symbiotics, defined as the convergence of human science + computer science. Khaderi developed the discipline of Symbiotics following initial interest from CS students interested in his research at the Stanford Human Perception Lab. Symbiotics involves a deep understanding in the principles of human systems and applying these principles computationally, to design and develop the next generation of human-centric technologies, where machines perceive, understand and respond to optimize the human experience. Dr. Khaderi envisions the application of Symbiotic principles as the key to unlocking ambient intelligence.
Khaderi has extensive domain expertise in artificial intelligence (AI), spatial computing (virtual reality (VR), augmented reality (AR), mixed reality (MxR)), wearables, gaming, IoT, Web3, applied neuroscience, human factors, and human-machine interfaces/interaction. His research interests include developing personalized human intelligent systems based on the human brain and sensory systems, developing technologies to optimize human performance, and combining biological and computational principles to expand our capabilities in research, clinical practice, and everyday life. Dr. Khaderi's approach to advance research interests and develop practical applications for everyday use is building technology, companies and collaborative partnerships across academia and industry.
Dr. Khaderi’s experience across industry sectors include consumer electronics, gaming, retail, life science, sports/Esports health care, Pharma, e-commerce, to name a few. He has developed novel technologies in these areas, and generated multiple invention patents. Selected as a “40 under 40”, he contributed to President Obama’s Council of Advisors on Science and Technology regarding vision technology and the aging population. He also advises multiple companies, venture firms and organizations including Apple, Google, Meta, Microsoft, Riot Games, Intel, Activision, Unity, Epic Games, NBA, Glaukos, the Global Esports Federation, the World Health Organization, the International Olympic Committee, the International Telecommunication Union, and the World Bank. -
Oussama Khatib
Weichai Professor and Professor, by courtesy, of Electrical Engineering
BioRobotics research on novel control architectures, algorithms, sensing, and human-friendly designs for advanced capabilities in complex environments. With a focus on enabling robots to interact cooperatively and safely with humans and the physical world, these studies bring understanding of human movements for therapy, athletic training, and performance enhancement. Our work on understanding human cognitive task representation and physical skills is enabling transfer for increased robot autonomy. With these core capabilities, we are exploring applications in healthcare and wellness, industry and service, farms and smart cities, and dangerous and unreachable settings -- deep in oceans, mines, and space.
-
Paul A. Khavari, MD, PhD
Carl J. Herzog Professor of Dermatology in the School of Medicine
Current Research and Scholarly InterestsWe work in epithelial tissue as a model system to study stem cell biology, cancer and new molecular therapeutics. Epithelia cover external and internal body surfaces and undergo constant self-renewal while responding to diverse environmental stimuli. Epithelial homeostasis precisely balances stem cell-sustained proliferation and differentiation-associated cell death, a balance which is lost in many human diseases, including cancer, 90% of which arise in epithelial tissues.
-
Chaitan Khosla
Wells H. Rauser and Harold M. Petiprin Professor and Professor of Chemistry and, by courtesy, of Biochemistry
Current Research and Scholarly InterestsResearch in this laboratory focuses on problems where deep insights into enzymology and metabolism can be harnessed to improve human health.
For the past two decades, we have studied and engineered enzymatic assembly lines called polyketide synthases that catalyze the biosynthesis of structurally complex and medicinally fascinating antibiotics in bacteria. An example of such an assembly line is found in the erythromycin biosynthetic pathway. Our current focus is on understanding the structure and mechanism of this polyketide synthase. At the same time, we are developing methods to decode the vast and growing number of orphan polyketide assembly lines in the sequence databases.
For more than a decade, we have also investigated the pathogenesis of celiac disease, an autoimmune disorder of the small intestine, with the goal of discovering therapies and related management tools for this widespread but overlooked disease. Ongoing efforts focus on understanding the pivotal role of transglutaminase 2 in triggering the inflammatory response to dietary gluten in the celiac intestine.
